Chinese Regulations on In-Vitro Diagnostic Reagents Market: Application & Approval 2014 Edition New Study Now Available at MarketReportsOnline.com
Dallas, Texas (PRWEB) September 30, 2014 -- China’s regulatory framework for in-vitro diagnostic reagents is undergoing earthshaking changes. The country’s new leaders have recognized that the regulations for supervision and administration of in-vitro diagnostic reagents are far from perfect along with rapid population growth and thriving economy over the past 30 years. Chinese state council issued the latest “Regulations for the Supervision and Administration of Medical Devices” on February 12, 2014, and it has come into force as June 1, 2014. Before long, China Food and Drug Administration issued a series of the latest regulations on in-vitro diagnostic reagents on July 30, 2014 respectively, and they will come into force as October 1, 2014. The overseas in-vitro diagnostic reagents exporting into China market will be subject to administration of overall new regulations on in-vitro diagnostic reagent registration since October 1, 2014.
Purchase a copy of this research report @ http://www.marketreportsonline.com/contacts/purchase.php?name=148939.
Key Companies Mentioned: Life Technologies, Roche, Abbott, Siemens, Beja Asian capital
China is one of the fastest growing global economies with a fifth population in the world, and is one of the largest healthcare markets around the world. Along with sustained economic and population growth as well as an ageing population, Chinese healthcare market has maintained annually average growth rate above 16 % since 1990s. Among them, in-vitro diagnostic reagents represented dynamical growth since 2007. By 2013, total value of in-vitro diagnostic reagents on Chinese healthcare market has reached 3.5 billion US dollars, an increase of 22.9% over 2012 level. It is estimated that Chinese in-vitro diagnostic reagent market is likely to be more than 5.5 billion US dollars until 2015, and it is one of segment market of the most growth potentiality.
Report Highlights
An analysis and research for radical change of Chinese regulations on in-vitro diagnostic reagents. An overview of the latest Chinese applicable regulations for for in-vitro diagnostic reagent registration. An overview of organizational structure of Chinese regulatory authorities for imported overseas in-vitro diagnostic reagent registration and recordation to give the direction of gateway for imported overseas in-vitro diagnostic reagent registration.
The Chinese general regulations for imported overseas in-vitro diagnostic reagent registration to let overseas in-vitro diagnostic reagent manufacturer understand the unique Chinese approach for in-vitro diagnostic reagent registration and lay the knowledge foundation for the practical operation.
The detailed Chinese classification and naming principles for in-vitro diagnostic reagents. The Chinese unique requirements for clinical trials of in-vitro diagnostic reagents, from the basic principles of clinical trials, the clinical trial design, scheme and methods, the sample size of clinical trial, to the clinical trial report and protocol.
Complete report available @ http://www.marketreportsonline.com/148939.html.
Scope
Chapter 2 provides the analysis and research for radical change of Chinese regulations on in-vitro diagnostic reagents. Chapter 3 introduces the framework of the latest Chinese applicable regulations for in-vitro diagnostic reagent registration to provide a comprehensive and thorough knowledge of the latest Chinese regulations for in-vitro diagnostic reagent registration. Chapter 4 provides an overview of the Chinese regulatory authorities -- China Food and Drug Administration (CFDA) being responsible for approval for imported overseas in-vitro diagnostic reagent registration and recordation to give the direction of gateway for imported overseas in-vitro diagnostic reagent registration and recordation. Browse complete Table of Contents @ http://www.marketreportsonline.com/148939-toc.html.
Chapter 5 elaborates the general regulations for imported overseas in-vitro diagnostic reagent registration to let overseas in-vitro diagnostic reagent manufacturer understand the unique Chinese approach for in-vitro diagnostic reagent registration and lay the knowledge foundation for the practical operation. Chapter 6 elaborates the classification and naming principles for in-vitro diagnostic reagents to let overseas in-vitro diagnostic reagent manufacturer understand the Chinese in-vitro diagnostic reagent classification and nomenclature, because the imported overseas in-vitro diagnostic reagent registration must be in compliance with such classification and nomenclature of in-vitro diagnostic reagents. Chapter 7 introduces the Chinese unique requirements for clinical trials of in-vitro diagnostic reagents, from the basic principles of clinical trials, the clinical trial design, scheme and methods, the sample size of clinical trial, to the clinical trial report and protocol step by step.
Related Reports on Pharmaceuticals Market:
The US Specialty Pharmaceutical Market Report: 2013 Edition @ http://www.marketreportsonline.com/316585.html.
Global In Vitro Diagnostics (IVD) Market Report: 2013 Edition @ http://www.marketreportsonline.com/303215.html.
Global Knee & Hip Market Report: 2013 Edition @ http://www.marketreportsonline.com/301702.html.
About Us:
MarketReportsOnline.com is an online database of regional industry research reports, company profiles and SWOT analysis studies for multiple industries, organizations and market segments. Our sales and research experts offer 24 X 7 supports to our customers through phone and email communication. Not limited to the pharmaceuticals, MarketReportsOnline.com offers research studies on medical devices, chemicals, agriculture, environment, biotechnology, agriculture, retail, energy and power, semiconductor and electronics, it & telecommunication, food and beverages, advanced materials, consumer goods, mining & utilities, banking and financial services, travel & hospitality, healthcare and much more.
Ritesh Tiwari, Market Reports Online, http://www.marketreportsonline.com/, +1 (888) 391-5441, [email protected]
Share this article